A case of renal pelvic tumor visualized by 18F-FDG-PET imaging

Annals of Nuclear Medicine

Volumn 18, Issue 2, 2004, Pages 161-163

  Watanabe, Naoto ^a   Kato, Hiroshi ^a   Shimizu, Masashi ^a   Noguchi, Kyo ^a   Kamisaki, Yuichi ^a   Fuse, Hideki ^a   Matsunari, Ichiro ^b   Hisada, Kinichi ^b   Seto, Hikaru ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Med and Pharmacol Res Foundation

Author keywords

18F FDG PET; Renal pelvic tumor; Transitional cell carcinoma; Tumor imaging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; DIAGNOSTIC IMAGING; HUMAN; KIDNEY CARCINOMA; KIDNEY CORTEX; KIDNEY PELVIS TUMOR; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; PARAAORTIC LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TUMOR DIAGNOSIS;

EID: 3042788558     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02985108     Document Type: Article

References (9)

1. Catalona WJ, Messing EM. Urothelial tumors of the renal pelvis and ureter. In: Walsh PC, Retic AB, Vaugham ED, et al., eds. Campbell's urology, 7th ed. Philadelphia; WB Saunders, 1988: 2383-2410.
2. Leder RA, Dunnick NR. Transitional cell carcinoma of the pelvicalices and ureter. AJR 1990; 155: 713-722.
3. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991; 32: 623-648.
4. Ramdave S, Thomas GW, Berlangieri SU, Bolton DM, Davis I, Danguy HT, et al. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol 2001; 166: 825-830.
5. Kosuda S, Kison PV, Greenough R, Grossman HB, Wahl RL. Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer. Eur J Nucl Med 1997; 24: 615-620.
6. 18F)-fluoro-D-glucose: pilot animal and human studies. J Urol 1991; 146: 1470-1474.
7. Hubner HF. Gynecologic and genitourinary. Wahl RL, ed. Principles and Practice of Positron Emission Tomography. Philadelphia, USA; Lippincott Williams & Wilkins, 2002: 234-245.
8. Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, De Wever WF, Verbeken EK, et al. FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group. Eur J Nucl Med 1998; 25: 1495-1501.
9. 18F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients. J Nucl Med 2003; 44: 1775-1783.